S&P 500
5.219,62 -3,06 (-0,06%) Nasdaq
16.381,56 +40,69 (+0,25%) NIKKEI 225
38.179,46 -49,65 (-0,13%) Dólar/Euro
1,0796 +0,0023 (+0,22%) Petróleo Brent
83,05 +0,26 (+0,31%) Bitcoin EUR
58.229,41 +1.325,57 (+2,33%)
Creative Medical Technology Holdings, Inc. (CELZ)
Creative Medical Technology Holdings, Inc.
211 East Osborn Road
Phoenix, AZ 85012
United States
(480) 399-2822
https://www.creativemedicaltechnology.com
Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 4
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Timothy Warbington | Co-Founder, Chairman, President & CEO | 522,62k | N/A | 1962 |
| Mr. Donald Dickerson | Senior VP, CFO & Director | 467,25k | N/A | 1965 |
Descripción
Creative Medical Technology Holdings, Inc., a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Gobierno corporativo
El ISS Governance QualityScore de Creative Medical Technology Holdings, Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
